KNOBELMAN DEBORAH
Insider CIK 1931509 · KRON President & Interim CEO · SNTI Chief Financial Officer
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| KRON Kronos Bio, Inc. | D To issuer deriv | 2025-06-20 | 2025-06-20 | 246,390 | — | $0 | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | U Tender | 2025-06-20 | 2025-06-20 | 139,422 | $0.57 | $79.5K | 0 | SEC↗ |
| KRON Kronos Bio, Inc. | S Sale | 2025-06-05 | 2025-06-06 | 24,838 | $0.87 | $21.6K | 139,422 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award deriv | 2024-06-03 | 2024-06-04 | 246,390 | — | $0 | 246,390 | SEC↗ |
| KRON Kronos Bio, Inc. | A Award | 2024-06-03 | 2024-06-04 | 164,260 | — | $0 | 164,260 | SEC↗ |
| SNTI Senti Biosciences, Inc. | A Award deriv | 2024-02-01 | 2024-02-02 | 152,000 | — | $0 | 152,000 | SEC↗ |
| SNTI Senti Biosciences, Inc. | A Award | 2024-02-01 | 2024-02-02 | 101,000 | — | $0 | 131,000 | SEC↗ |
| SNTI Senti Biosciences, Inc. | A Award deriv | 2023-02-01 | 2023-02-02 | 130,000 | — | $0 | 130,000 | SEC↗ |
| SNTI Senti Biosciences, Inc. | A Award deriv | 2022-10-03 | 2022-10-04 | 240,000 | — | $0 | 240,000 | SEC↗ |
| SNTI Senti Biosciences, Inc. | A Award | 2022-10-03 | 2022-10-04 | 30,000 | — | $0 | 30,000 | SEC↗ |